Evidence map›Paper›PMID 42128848›Full record

ReviewEndocrine journal2026

Efficacy of iodine-131-metaiodobenzylguanidine therapy for multiple endocrine neoplasia type 2A-associated metastatic pheochromocytoma: case report and literature review.

Kentaro Suda, Noriko Kimura, Toshihiro Maeda, Shiro Watanabe, Sachiyo Nishida, Hiroaki Shima, Taro Sugawara, Shinya Uchino, Aki Ishikawa, Toshiaki Tanaka and 3 more

Abstract readCase ReportsReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Endocrine journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Kentaro SudaDivision of Clinical Genomics, Department of Genomic and Preventive Medicine, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID http://orcid.org/0000-0001-6734-5183
Noriko KimuraDepartment of Diagnostic Pathology, National Hospital Organization Hakodate Medical Center, Hakodate 041-8512, Japan.
Toshihiro MaedaDepartment of Urology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Shiro WatanabeDepartment of Nuclear Medicine, Hokkaido University Hospital, Sapporo 060-8648, Japan.
Sachiyo NishidaDepartment of Urology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Hiroaki ShimaDepartment of Surgery, Surgical Oncology and Science, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Taro SugawaraDepartment of Surgical Pathology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Shinya UchinoDepartment of Surgery, Noguchi Thyroid Clinic and Hospital Foundation, Beppu 874-0902, Japan.
Aki IshikawaDivision of Clinical Genomics, Department of Genomic and Preventive Medicine, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Toshiaki TanakaDepartment of Urology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Masato FuruhashiDepartment of Cardiovascular, Renal and Metabolic Medicine, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.ORCID http://orcid.org/0000-0002-0145-3541
Naoya MasumoriDepartment of Urology, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.
Akihiro SakuraiDivision of Clinical Genomics, Department of Genomic and Preventive Medicine, School of Medicine, Sapporo Medical University, Sapporo 060-8556, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant transformation in multiple endocrine neoplasia type 2 (MEN2)-associated pheochromocytoma is rare, and there have been few reports of treatment with

Indexed as

3-IodobenzylguanidineAdrenal Gland NeoplasmsCarcinoma, NeuroendocrineIodine RadioisotopesMultiple Endocrine Neoplasia Type 2aPheochromocytomaThyroid NeoplasmsAdrenalectomyFemaleHumansMiddle AgedProto-Oncogene Proteins c-retThyroidectomy3-IodobenzylguanidineIodine-131Iodine RadioisotopesProto-Oncogene Proteins c-retIodine-131-metaiodobenzylguanidine therapyMetastatic pheochromocytomaMultiple endocrine neoplasia type 2

Identifiers

PMID42128848
PMCPMC13378842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.